Literature DB >> 21503833

Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment.

Jeffrey S Gonzalez1, Christina Psaros, Abigail Batchelder, Allison Applebaum, Howard Newville, Steven A Safren.   

Abstract

BACKGROUND: The impact of measurement methods on the relationship between depression and HIV treatment adherence has not been adequately examined.
PURPOSE: The purpose of this paper is to examine the relationship between clinician- and patient-rated depression and HIV medication adherence.
METHODS: The participants were 91 HIV-infected individuals in methadone maintenance. Depression was assessed via clinician ratings (Clinical Global Impression Scale and Montgomery Asberg Depression Rating Scale) and self-report (Beck Depression Inventory-Short Form). Clinicians rated substance abuse using the Clinical Global Impression Scale and a structured interview. HIV medication adherence was measured over the following 2 weeks using electronic caps.
RESULTS: Each unit increase in the Clinical Global Impression Scale was associated with 75% increased odds of nonadherence (OR=1.75, p=0.002, 95% CI=1.23-2.48). Similarly, for each standard deviation Montgomery Asberg Depression Rating Scale increase, there was a 2.6-fold increased odds of nonadherence (OR=2.60, p=0.001, 95% CI=1.45-4.67). Substance abuse and self-reported depression severity were not significantly related to adherence.
CONCLUSIONS: Clinician-rated depression severity was a strong predictor of nonadherence. Assessment methods may influence the relationship between depression and HIV nonadherence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503833      PMCID: PMC3639471          DOI: 10.1007/s12160-011-9268-y

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  21 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.

Authors:  Tracy R Glass; Sabina De Geest; Bernard Hirschel; Manuel Battegay; Hansjakob Furrer; Matthias Covassini; Pietro L Vernazza; Enos Bernasconi; Martin Rickenboch; Rainer Weber; Heiner C Bucher
Journal:  Antivir Ther       Date:  2008

4.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

5.  Predictors of nonadherence to HIV-related medication regimens during methadone stabilization.

Authors:  S K Avants; A Margolin; L A Warburton; K A Hawkins; J Shi
Journal:  Am J Addict       Date:  2001

6.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

7.  Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients.

Authors:  Richard A Hansen; Stacie B Dusetzina; Liping Song; Bradley N Gaynes; Wanzhu Tu; Michael D Murray
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Nov-Dec

8.  Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.

Authors:  Joan S Tucker; M Audrey Burnam; Cathy D Sherbourne; Fuan-Yue Kung; Allen L Gifford
Journal:  Am J Med       Date:  2003-05       Impact factor: 4.965

9.  Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV.

Authors:  Conall O'Cleirigh; Gail Ironson; Alexander Weiss; Paul T Costa
Journal:  Health Psychol       Date:  2007-07       Impact factor: 4.267

10.  Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS.

Authors:  Tania Gibbie; Margaret Hay; Chris W Hutchison; Anne Mijch
Journal:  Sex Health       Date:  2007-12       Impact factor: 2.706

View more
  17 in total

1.  Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.

Authors:  Lauren M Hill; Carol E Golin; Nisha C Gottfredson; Brian W Pence; Bethany DiPrete; Jessica Carda-Auten; Jennifer S Groves; Sonia Napravnik; David Wohl; Kevin Knight; Patrick M Flynn
Journal:  AIDS Behav       Date:  2019-08

Review 2.  Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.

Authors:  Mollie E Miller; Stacey C Sigmon
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

3.  Effects of syndemic psychiatric diagnoses on health indicators in men who have sex with men.

Authors:  Abigail W Batchelder; Karmel Choi; Sannisha K Dale; Catherine Pierre-Louis; Elsa W Sweek; Gail Ironson; Steven A Safren; Conall O'Cleirigh
Journal:  Health Psychol       Date:  2019-04-11       Impact factor: 4.267

4.  Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers.

Authors:  Kristine K Browning; Mary Ellen Wewers; Amy K Ferketich; Philip Diaz; Susan L Koletar; Nancy R Reynolds
Journal:  AIDS Behav       Date:  2016-03

5.  Examination of the Role of Religious and Psychosocial Factors in HIV Medication Adherence Rates.

Authors:  Safiya George Dalmida; Katryna McCoy; Harold G Koenig; Aretha Miller; Marcia McDonnell Holstad; Tami Thomas; Dora Clayton-Jones; Mary Grant; Terri Fleming; Menka Munira Wirani; George Mugoya
Journal:  J Relig Health       Date:  2017-12

Review 6.  Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes.

Authors:  Aaron J Blashill; Nicholas Perry; Steven A Safren
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

7.  Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?

Authors:  Jessica F Magidson; Alyson Listhaus; C J Seitz-Brown; Steven A Safren; C W Lejuez; Stacey B Daughters
Journal:  J Behav Med       Date:  2014-11-09

Review 8.  Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.

Authors:  Jeffrey S Gonzalez; Abigail W Batchelder; Cristina Psaros; Steven A Safren
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

9.  Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center.

Authors:  Jessica F Magidson; C J Seitz-Brown; Steven A Safren; Stacey B Daughters
Journal:  Cogn Behav Pract       Date:  2014-11-01

10.  The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.

Authors:  Howard Newville; Karina M Berg; Jeffrey S Gonzalez
Journal:  Int J Behav Med       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.